- Report
- March 2024
- 194 Pages
Global
From €3217EUR$3,374USD£2,749GBP
€3574EUR$3,749USD£3,054GBP
- Report
- May 2024
- 194 Pages
Global
From €4719EUR$4,950USD£4,032GBP
- Report
- October 2023
- 150 Pages
Global
From €4624EUR$4,850USD£3,951GBP
- Report
- October 2023
- 152 Pages
Global
From €4243EUR$4,450USD£3,625GBP
- Report
- April 2024
- 1800 Pages
Global
From €3809EUR$3,995USD£3,254GBP
- Report
- May 2024
- 500 Pages
Global
From €3809EUR$3,995USD£3,254GBP
- Report
- May 2024
- 500 Pages
Global
From €3809EUR$3,995USD£3,254GBP
- Report
- May 2024
- 182 Pages
Global
From €3217EUR$3,374USD£2,749GBP
€3574EUR$3,749USD£3,054GBP
- Report
- May 2024
- 915 Pages
Global
From €5196EUR$5,450USD£4,440GBP
- Report
- October 2023
- 190 Pages
Global
From €4672EUR$4,900USD£3,992GBP
- Report
- September 2023
- 216 Pages
Global
From €3037EUR$3,185USD£2,594GBP
€4338EUR$4,550USD£3,706GBP
- Report
- October 2023
- 152 Pages
Global
From €4243EUR$4,450USD£3,625GBP
- Report
- August 2021
- 1800 Pages
Global
From €2431EUR$2,550USD£2,077GBP
€2860EUR$3,000USD£2,444GBP
- Report
- October 2022
- 150 Pages
Global
From €5673EUR$5,950USD£4,847GBP
- Report
- March 2023
- 113 Pages
Global
From €4672EUR$4,900USD£3,992GBP
- Report
- September 2022
- 288 Pages
Global
From €9058EUR$9,500USD£7,739GBP
- Report
- September 2022
- 144 Pages
Global
From €4529EUR$4,750USD£3,869GBP
- Report
- January 2021
- 120 Pages
Global
From €2384EUR$2,500USD£2,036GBP
- Report
- May 2024
- 200 Pages
From €3957EUR$4,150USD£3,381GBP
- Report
- April 2019
- 109 Pages
Global
€2860EUR$3,000USD£2,444GBP
The Cancer Gene Therapy market is a subset of the larger Genomics market, which focuses on the study of genes and their functions. Cancer Gene Therapy is a form of treatment that uses genetic material to treat or prevent cancer. It involves introducing genetic material into cells to modify their behavior, such as to stop the growth of cancer cells or to make them more sensitive to chemotherapy. This type of therapy has the potential to be more effective and less toxic than traditional treatments.
Cancer Gene Therapy is still in its early stages of development, but it has the potential to revolutionize cancer treatment. It is being studied in clinical trials and is expected to become more widely available in the future.
Companies in the Cancer Gene Therapy market include Editas Medicine, Intellia Therapeutics, CRISPR Therapeutics, and Allergan. Show Less Read more